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Ectromelia virus (ECTV) is a natural pathogen of mice that causes mousepox, and many of its genes have been
implicated in the modulation of host immune responses. Serine protease inhibitor 2 (SPI-2) is one of these putative
ECTV host response modifier proteins. SPI-2 is conserved across orthopoxviruses, but results defining its mecha-
nism of action and in vivo function are lacking or contradictory. We studied the role of SPI-2 in mousepox by deleting
the SPI-2 gene or its serine protease inhibitor reactive site. We found that SPI-2 does not affect viral replication or
cell-intrinsic apoptosis pathways, since mutant viruses replicate in vitro as efficiently as wild-type virus. However, in
the absence of SPI-2 protein, ECTV is attenuated in mousepox-susceptible mice, resulting in lower viral loads in the
liver, decreased spleen pathology, and substantially improved host survival. This attenuation correlates with more
effective immune responses in the absence of SPI-2, including an earlier serum gamma interferon (IFN-) response,
raised serum interleukin 18 (IL-18), increased numbers of granzyme B CD8 T cells, and, most notably, increased
numbers and activation of NK cells. Both virus attenuation and the improved immune responses associated with
SPI-2 deletion from ECTV are lost when mice are depleted of NK cells. Consequently, SPI-2 renders mousepox
lethal in susceptible strains by preventing protective NK cell defenses.
Ectromelia virus (ECTV) is a large DNA virus and the
causative agent of mousepox. This poxvirus has been long
established as a classical model to study acute viral pathogen-
esis. ECTV carries 175 genes, and approximately 25% of the
gene products are thought to be mediators of host immune
evasion by targeting diverse processes, such as cellular signal-
ing, intrinsic and extrinsic cell death pathways, and compo-
nents of the innate immune response (6).
Host immune response modulation by poxviruses is essential
for virulence and progeny production, with gene deletions of
many of the immune host response modifiers resulting in virus
attenuation (1, 47–49, 54). The first orthopoxvirus gene prod-
uct found to be associated with evasion of the host immune
system was the cytokine response modifier A gene (crmA) from
cowpox virus (CPXV) (41). CrmA is one of three serine pro-
teinase inhibitors (serpins or SPI proteins) encoded by such
viruses and is referred to here as SPI-2. SPI-2 is highly con-
served among orthopoxviruses (90% amino acid sequence
identity), such as ECTV, vaccinia virus (VACV), and variola
virus (VARV) (51), and orthologues can also be found outside
the genus, for example, in myxoma virus (MYXV). Despite this
conservation, a single common role for SPI-2 in poxvirus biol-
ogy has so far not been identified, given that SPI-2 deletions in
CPXV and VACV have varying effects in vivo, depending on
the virus, host, and mode of infection (25, 28, 30, 41, 49), and
orthologues from CPXV and MYXV are not functionally in-
terchangeable (39).
Different serpins inhibit distinct types of proteinases. Thus
far, caspase 1 (24, 27, 45), caspase 8 (11, 24), and granzyme B
(44) have been shown to be targets of CPXV and/or VACV
SPI-2 protein. Still, ECTV SPI-2 was observed to inhibit in
vitro caspase 1 and caspase 8 but not granzyme B, despite the
high level of conservation among orthopoxvirus SPI-2 proteins
(50). The amino acids responsible for this apparent difference
in specificity remain to be identified, and the question of
whether they contribute to the differences seen in vivo remains
to be answered. Thus, despite extensive studies, the role of
SPI-2 in poxvirus infection is still poorly understood. There is
contradictory evidence as to whether SPI-2 affects virus repli-
cation in vivo (28, 30). In addition, the wide range of targets
identified for SPI-2 in vitro suggests a number of possible roles,
from interference with cytolytic lymphocyte-mediated killing of
infected cells (37) to inhibition of cleavage activation of pro-
inflammatory cytokines, such as interleukin 1 (IL-1) (24, 27,
45, 50) and IL-18.
In the present work, we generated ECTV SPI-2 mutants and
examined the in vivo function of this viral gene product in the
pathogenesis of mousepox, i.e., in a natural host-pathogen
relationship. We found that SPI-2 is an important virulence
factor that mediates its effects primarily via prevention of NK
cell responses.
MATERIALS AND METHODS
Ethics statement. This study was carried out in strict accordance with the
recommendations of the Australian Code of Practice for the Care and Use of
Animals for Scientific Purposes. The protocol was approved by the Animal
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Experimentation Ethics Committee (AEEC) of the Australian National Univer-
sity (protocol number J.IG.68.08). All efforts were made to minimize suffering.
Mice and cells. Eight- to 10-week-old female C57BL/6 and BALB/c mice were
obtained from the specific-pathogen-free facility at the John Curtin School of
Medical Research (JCSMR) (Canberra, Australia) or the Animal Resources
Centre (Perth, Australia) and used according to institutional experimentation
approval. BS-C-1, a continuous African green monkey kidney cell line; L929, a
continuous fibroblast line from the C3H mouse; and mouse embryonic fibro-
blasts (MEF) (26) were maintained in Eagle’s minimal essential medium
(EMEM) plus 5% fetal bovine serum and antibiotics at 37°C in a humidified
atmosphere with 5% CO2.
Viruses. Plaque-purified ECTV (Moscow strain) and recombinant viruses
were propagated in murine L929 cells as previously described (7). Virus titers
were determined by plaque assay on BS-C-1 monolayers. For virus multistep
growth curves, L929 cell and MEF lines were infected at a multiplicity of infec-
tion (MOI) of 3 for 1 h. Unabsorbed virus was washed off, and fresh medium was
added. At various times postinfection (p.i.), the cell culture and cell-associated
material were harvested separately, and virus titers were determined by plaque
assay using BS-C-1 monolayers.
Recombinant virus generation. Two ECTV SPI-2-deficient viruses containing
different genetic modifications in the SPI-2 gene (locus ECTVgp162 of ECTV
Moscow; NCBI accession NC_004105.1; product also known as EVM161 and
serpin C7L) were generated. ECTV SPI-2 was generated by a general transient-
dominant selection method used for constructing poxvirus mutants based on
-galactosidase (-Gal) gene expression and Escherichia coli gpt with mycophe-
nolic acid selection (12, 13). The complete SPI-2 gene sequence was deleted.
ECTV SPI-2 SAD and ECTV SPI-2 REV were generated by a novel transient-
dominant selection method using green fluorescent protein (GFP) fluorescence
and blasticidin resistance as selection markers (53). Nucleotides 271 to 698
were deleted in the open reading frame of ECTV SPI-2 SAD. The deletion
process inserts the AATGACGGCGAT exogenous sequence into the gene,
generating a frameshift and an early stop codon in the mutant predicted protein.
As a consequence, only amino acids 1 to 91 of the wild-type (wt) SPI-2 protein
are expressed in ECTV SPI-2 SAD. ECTV SPI-2 REV was generated from the
ECTV SPI-2 SAD mutant. Blasticidin was purchased from Invivogen. Gene
deletion/restoration was confirmed by PCR and sequencing.
Western blotting. For analysis of SPI-2 expression, 1  107 MEF were infected
at an MOI of 10 for 4 h at 35°C. Cell lysates were prepared by cell pellet
resuspension with radioimmunoprecipitation assay lysing buffer (25 mM Tris-
HCl, pH 8, 137 mM sodium chloride, 2 mM EDTA, 1% glycerol, 1% NP-40,
0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS]). Lysates were
cleared using QIAshredder columns (Qiagen), separated by SDS-polyacrylamide
gel electrophoresis with 12% gels, and blotted against nitrocellulose membranes
(Bio-Rad). SPI-2 protein was detected using a mouse anti-SPI-2 monoclonal
antibody (BD-Pharmingen; catalog no. 65921A; dilution, 1/400) as the primary
antibody, a secondary anti-mouse IgG1 peroxidase-coupled antibody (BD Phar-
mingen), and enhanced chemiluminescence substrate (Amersham). For actin
detection, a rabbit anti-actin polyclonal antibody (Santa Cruz) was used, fol-
lowed by anti-rabbit IgG peroxidase-coupled antibody (BD Pharmingen).
Infections. For in vivo studies of ECTV pathogenesis, mice were infected with
103 PFU or 106 PFU subcutaneously (s.c.) in both hind legs in a total volume of
50 l phosphate-buffered saline (PBS) (25 l per leg). The mice were monitored
daily by blinded examiners for signs of mousepox, such as coat condition, con-
junctivitis, body paralysis, and limb swelling. Mice were euthanized if disease
manifestations were extremely severe in one or more illness parameters based on
a numeric score. Scores of 1 to 3 were assigned to each disease parameter, and
mice with a score of 3 in one parameter or 5 in cumulative parameters were
sacrificed. Coat condition scores were as follows: 1, slightly rough; 2, disheveled/
wounds forming; 3, bleeding or irritated wounds/severe hair loss. Eye condition
scores were as follows: 1, mild discharge; 2, severe conjunctivitis. Movement
scores were as follows: 1, abnormal/uncoordinated; 2, walking on tiptoe/reluctant
to move; 3, staggering/paralysis. Limb condition scores were as follows: 1, swell-
ing; 2, abnormal limbs; 3, severe necrosis/loss of limbs.
Virus titration of organs, histological evaluation, and liver enzyme and cyto-
kine levels in the serum. Mice were infected s.c. with 103 PFU and sacrificed at
the indicated times p.i. for organ and serum collection. Liver, spleen, and lung
samples were homogenized in a medium volume proportional to the sample
weight (grams  9  ml). Popliteal draining lymph node samples were homog-
enized in a fixed volume of medium. The viral load was quantified by plaque
assay using BS-C-1 monolayers. Histology samples were fixed in 10% formalin,
and paraffin-embedded tissue sections were stained with hematoxylin and eosin
(H&E) or with DAPI (4-6-diamidino-2-phenylindole) (Sigma) and the Dead
End Fluorometric TUNEL System (Promega) according to the manufacturers’
protocols. The percentages of apoptotic cells measured by terminal deoxynucle-
otidyltransferase dUTP nick end labeling (TUNEL) staining were manually
counted as the green fluorescent (TUNEL) cells colocalized with blue fluores-
cent (DAPI) cells within the total DAPI cell population. For each mouse
sample, 	500 cells were analyzed in 5 different regions of the tissue section
visualized in a Leica TCS SP5 confocal microscope. Liver enzyme (alanine
aminotransferase [ALT] and aspartate aminotransferase [AST]) levels in the
serum were determined at the ACT Pathology Unit of the Canberra Hospital,
Australia. The levels of the cytokines mouse gamma interferon (IFN-
), tumor
necrosis factor alpha (TNF-), IL-2, IL-4, IL-10, IL-6, and IL-17A in the serum
were quantified with the BD CBA mouse Th1/Th2/Th17 cytokine kit (BD Bio-
sciences). The levels of IL-18 and IL-1 in the sera of infected mice were
determined by the mouse IL-18 ELISA (Bender MedSystems) and the BD
OptEIA mouse IL-1 ELISA set (BD Biosciences), respectively. For IFN-
detection, rabbit polyclonal antibody against mouse IFN- (PBL interferon
source 32400-1) and rat monoclonal antibody against mouse IFN- (RMMB-1)
(PBL interferon source 22400-1) were used in a capture enzyme-linked immu-
nosorbent assay (ELISA).
Flow cytometry. Infected mice were sacrificed at the indicated times p.i., and
spleens and blood were collected. Single-splenocyte suspensions were obtained
by pressing organs through cell strainers, followed by hypotonic red blood cell
lysis. Total splenocyte numbers were determined by counting, and 106 cells per
sample were analyzed by fluorescence-activated cell sorter (FACS). Twenty-five
microliters of each blood sample treated with heparin, followed by red blood cell
lysis, was used for FACS staining. Splenocytes and blood cells were incubated in
7-amino actinomycin D (7AAD) and stained for CD8 allophycocyanin (APC)-
conjugated clone 53-6.7 (BD Pharmingen), CD8 fluorescein isothiocyanate
(FITC)-conjugated clone 53-6.7 (BD Pharmingen), CD4 FITC-conjugated clone
H129.19 (BD Pharmingen), B220 phycoerythrin (PE)-conjugated clone RA3-
6B2 (BD Pharmingen), F4-80 FITC-conjugated clone CI:A3-1 (AbD Serotec),
and CD49b Alexa Fluor 647-conjugated clone DX5 (BioLegend). The cells were
then fixed with fixation buffer (BioLegend), permeabilized with 0.5% saponin,
and stained with polyclonal rabbit anti-granzyme B serum (a gift from Markus
Simon, Max Planck Institute, Freiburg, Germany) or preimmune rabbit serum,
followed by Alexa Fluor 647-conjugated (Molecular Probes) or PE-conjugated
(Caltag Laboratories) rat anti-rabbit IgG. For apoptosis assays, MEF were in-
fected as described above, and at the indicated hours p.i., the cells were stained
using the Annexin V-PE Apoptosis Detection kit I (BD Pharmingen) or with
3,3-dihexyloxacarbocyanine iodide (DiOC6; Molecular Probes). The cells were
analyzed on a FACSCalibur flow cytometer (BD Biosciences) and with
WEASEL FACS software (Walter and Eliza Hall Institute of Medical Research,
Melbourne, Australia) or FlowJo (Flow Cytometry Analysis Software).
NK cell cytotoxic assay. Mice were infected s.c. with 103 PFU and sacrificed at
4 and 6 days p.i. Spleens were collected and tested for NK cytotoxicity in a
standard 51Cr release assay (34), using uninfected YAC-1 cells as targets. Un-
infected mice were used as controls. P values were calculated from specific lysis
from a four-point logarithmic regression curve, interpolated at an effector-to-
target (e/t) ratio of 30.
NK depletion. For NK depletion, 20 l of anti-asialo GM1 antiserum (Wako
Pure Chemical Industries, Ltd.) or 100 l of preimmune rabbit serum (Sigma),
each diluted to 200 l with PBS, was injected intraperitoneally (i.p.) 1 day before
virus infection, 2 days p.i., and 5 days p.i. Three mice per group were injected in
each of two independent experiments. In one experiment, PBS was injected as a
negative control, and in the other experiment, preimmune rabbit serum was used
as a negative control for NK cell depletion.
RESULTS
ECTV SPI-2 mutants and revertant. We generated two
ECTV SPI-2-deficient viruses containing different genetic
modifications in the SPI-2 gene. ECTV SPI-2 SAD was pro-
duced by deletion of 427 bp of the coding sequence, resulting
in the absence of the carboxy-terminal region in the SPI-2
protein. Most of the SPI-2 mRNA is not translated due to a
frameshift mutation in the coding sequence; however, a trun-
cated form of SPI-2 protein lacking the serpin reactive site
(LVSD) could be expressed. The second mutant, referred to as
ECTV SPI-2, was generated by deletion of the complete
gene. A revertant virus (ECTV SPI-2 REV) was generated by
restoring the wt SPI-2 gene on the ECTV SPI-2 SAD back-
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ground. The genetic profile of the recombinant viruses was
confirmed by PCR and sequencing. All of the remaining SPI-2
gene coding sequence plus 39 upstream nucleotides and 101
downstream nucleotides was determined by sequencing of
ECTV SPI-2 SAD. Two hundred forty upstream nucleotides
and 410 downstream nucleotides were determined by sequenc-
ing of ECTV SPI-2.
SPI-2 or a truncated form of the protein was not detected by
Western blot analysis of uninfected cells or cells infected with
ECTV SPI-2 SAD or ECTV SPI-2, whereas lysates of cells
infected with wt ECTV or ECTV SPI-2 REV presented a band
of the expected size for the full-length SPI-2 protein (see Fig.
S1 in the supplemental material). All samples expressed actin,
including uninfected cells.
Deletion of SPI-2 does not compromise virus growth in
vitro. To determine whether SPI-2 is required for efficient
replication in vitro, virus growth curves were established using
two different types of mouse cell lines. The recombinant vi-
ruses tested had replication efficiencies similar to that of wt
ECTV in L929 cells and MEF (Fig. 1A and B, respectively). In
agreement with this observation, the appearances of apoptotic
features triggered by infection were similar in wt virus and
mutants as measured by phosphatidylserine exposure (Fig. 1C)
and production of reactive oxygen species (data not shown).
Both SPI-2 mutant viruses induced less disruption of the mi-
tochondrial membrane potential than wt virus 24 h p.i., but the
difference was not statistically significant (Fig. 1D).
ECTV SPI-2 protein is a potent virulence factor in suscep-
tible mice. To study the importance of SPI-2 in viral patho-
genesis, C57BL/6 and BALB/c mice were infected s.c. with
either wt ECTV or recombinant virus. Disease signs, such as
disheveled coat, conjunctivitis, foot swelling, and movement im-
pairment, were recorded daily and scored. It is well established
that C57BL/6 mice are highly resistant (50% lethal dose [LD50] 	
105 PFU) whereas BALB/c mice are susceptible (LD50  10
PFU) to s.c. ECTV infection (2). Therefore, C57BL/6 mice were
infected with a high (106 PFU) or a low (103 PFU) dose of each
virus. BALB/c mice were infected with 103 PFU, which results in
100% mortality when wt ECTV is used.
All C57BL/6 mice infected with ECTV SPI-2 SAD or wt
virus survived for at least 4 weeks p.i. and showed few or no
disease signs, regardless of the dose given (data not shown). As
was expected, BALB/c mice infected with ECTV or ECTV
SPI-2 REV were highly susceptible to classical mousepox dis-
ease, and most animals succumbed to infection, with a median
survival time of 9 days p.i. Severe manifestations of disease
were frequently observed before mice were euthanized. In
contrast, 80 to 90% of mice infected with SPI-2-deficient vi-
ruses survived the infection (Fig. 2), although some signs of
illness, including disheveled coat, conjunctivitis, and limb
swelling were observed throughout the course of infection.
About half of the mice that survived ECTV SPI-2 mutant
infection still had detectable virus by 4 weeks p.i. (mean 
standard deviation [SD], 3.8  103  1.6  103 in the spleen
and 5.2  102  1.9  102 in the liver), suggesting that clear-
ance of the virus took longer than in mousepox infection of
resistant strains. By 8 weeks p.i., mutant viruses were no longer
detectable.
FIG. 1. In vitro replication and apoptosis induction of ECTV SPI-2 mutants is similar to that of wt virus. (A and B) L929 cells (A) and MEF
(B) were infected at an MOI of 3 with ECTV or ECTV SPI-2 mutants. The cell-associated viral load was quantified by plaque assay. The graphs
show means  standard errors of the mean (SEM) of one representative of three independent experiments. (C and D) MEF were infected as for
panel B. Infected-cell apoptosis (C) and mitochondrial potential disruption (D) were quantified by phosphatidylserine exposure (annexin
7AAD) and DiOC6 staining of MEF, respectively, at the indicated times p.i.
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Diminished viral loads in livers of mice infected with ECTV
in the absence of SPI-2. As the final cause of death in ECTV-
infected mice has been described in the literature as acute
hepatitis followed by multiorgan failure (18), it was of interest
to know whether the virus loads in various target organs, es-
pecially the liver, were affected by deletion of SPI-2 from
ECTV. Surprisingly, the viral loads in the spleen and popliteal
draining lymph nodes were similar for all viruses (Table 1). A
remarkably high viral load in the spleen was observed on day 4
and day 6 p.i. in mice infected with ECTV or ECTV SPI-2
mutants, and only a modest, but significant (P 	 0.05), reduc-
tion in titer was seen for ECTV SPI-2 SAD at 4 days p.i.
relative to wt virus (Table 1). On the other hand, the viral loads
in the liver increased more slowly, and at both days 4 and 6 p.i.,
ECTV SPI-2 mutants had replicated to lower levels than
ECTV (Table 1). The liver viral load decrease 6 days p.i. was
about 100-fold in ECTV SPI-2 SAD-infected mice and 10-
fold in ECTV SPI-2-infected mice compared to wt virus. In
another independent experiment, we found higher viral loads
(10-fold) in the livers of mice infected with 103 PFU of ECTV
SPI-2 REV than in the livers of mice infected with ECTV
SPI-2 SAD (P  0.0403) (data not shown). We also found
lower viral loads in the lungs of ECTV SPI-2 SAD mutant-
infected mice than in those of ECTV-infected mice (Table 1).
Liver and spleen pathology caused by mousepox is reduced
in the absence of SPI-2 protein. Next, we asked whether the
higher viral loads seen in livers of ECTV-infected mice than in
those of ECTV SPI-2 SAD-infected mice were associated
with a difference in overt liver pathology. Examination of liver
sections collected at days 6 and 9 p.i. revealed intense lympho-
cyte infiltration and several necrotic foci throughout the organ
in both groups but no obvious differences between the two
FIG. 2. ECTV SPI-2 mutants are strongly attenuated in vivo. (A) Female BALB/c mice were infected s.c. with 103 PFU of either ECTV, ECTV SPI-2
SAD, ECTV SPI-2, or ECTV SPI-2 REV. Illness signs were scored daily. “% survival” excludes dead and euthanized mice. The data from two
independent experiments were combined. (B and C) Illness signs for the two experiments pooled in the survival graph in panel A. Mice that were
euthanized or found dead were given the score on the day of euthanasia or 5, respectively, for the days following their death. *, P  0.05; **, 0.001 
P  0.01; ***, P  0.0001 in relation to both ECTV and ECTV SPI-2 REV. The error bars indicate standard errors of the means (SEM).
TABLE 1. Viral loads from target organs of mice infected with wt or mutant virus
Organ
Viral loada
Day 4 p.i. Day 6 p.i.
ECTV SPI-2 SAD SPI-2 ECTV SPI-2 SAD SPI-2
Lymph node 6.2  105  1.9  105 1.7  105  1.1  105 2.4  105  1.7  105 2.8  106  7.8  105 2.2  106  4.6  105 2.2  106  3.8  105
Spleen 4.3  107  1.0  107 1.1  107*  5.8  106 1.5  107  8.0  106 2.0  108  7.2  107 1.15  108  2.9  107 2.7  108  9.4  107
Liver 2.8  105  1.1  105 2.0  104*  6.3  103 6.0  104  9.0  103 1.3  108  3.3  107 9.9  105**  5.8  105 1.1  107**  1.0  107
Lung 3.5  103  1.2  103 4.1  103  2.5  103 NT 1.1  106  2.8  105 6.7  104**  1.4  104 NT
a BALB/c mice were infected s.c. with 103 PFU of ECTV or ECTV SPI-2 mutants. Viral loads in various organs at 4 and 6 days p.i. were determined by plaque assay.
The viral loads are given in PFU/lymph node or PFU/g of tissue for spleen, liver and lung. The assay detection limit was 102 PFU/g. The data shown are
means  standard errors of the mean (SEM) pooled from two independent experiments (n  3 for each experiment). , P  0.05, and , 0.001  P  0.01 in relation
to ECTV. NT, not tested.
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groups (see Fig. S2 in the supplemental material). In addition,
the overall liver structure was preserved, unlike the pathology
recorded after ECTV infection of highly susceptible perforin-
deficient C57BL/6 mice (38). However, the levels of two serum
markers of liver pathology, AST and ALT, were increased in
ECTV- but not ECTV SPI-2 SAD-infected mice (Fig. 3A and
B). The reduced viral loads in the liver and improved liver
function in mice infected with an ECTV mutant lacking SPI-2
suggest that the increased survival of these mice is linked to an
attenuation of the hepatitis caused by the wt ECTV infection
in BALB/c mice (18).
In contrast to the liver, a significant difference in histopa-
thology was found between the spleens of mice infected with wt
virus and those of mice infected with ECTV SPI-2 SAD. Wt
ECTV-infected mice presented spleens with massive tissue
destruction at day 6 p.i., whereas ECTV SPI-2 SAD-infected
mice presented markedly less tissue damage (Fig. 4B and C,
respectively). In accordance with this histological evidence of
widespread necrotic damage, the sizes of spleens from mice
infected with wt ECTV or ECTV SPI-2 REV were greatly
reduced macroscopically, and total splenocyte numbers were at
least 2-fold lower, compared to those from mice infected with
ECTV SPI-2 SAD or ECTV SPI-2 (Fig. 4D).
As a more direct measure of the damage to the liver and spleen
caused by infection, tissue sections were analyzed for the presence
of apoptotic cells presenting DNA fragmentation measured by
TUNEL staining (Fig. 5). Similar levels of apoptosis were found
in organs of mice infected with wt or mutant virus at day 4 p.i. In
both liver and spleen tissues, wt ECTV induced higher propor-
tions of TUNEL cells than ECTV SPI-2 SAD 6 days p.i.,
although the differences were not statistically significant.
Thus, although similar viral loads were observed in the
spleens of ECTV- and ECTV SPI-2 mutant-infected mice (Ta-
ble 1), indicating that on a per volume basis virus titers are
higher in wt virus-infected mice, the overall spleen destruction
caused by mousepox is greatly exacerbated in the presence of
the SPI-2 protein. In view of the comparable growth properties
of the mutant and wt viruses, the spleen protection observed in
mutant-infected mice suggests that the virulence factor SPI-2
thwarts immune-mediated control of ECTV infection.
IL-18 and IFN- production are enhanced in mice infected
with ECTV SPI-2 mutants. Host recovery from a primary
mousepox infection depends on the induction of a Th1-type
immune response and requires effective antiviral cytotoxic T
and NK cell immunity (3, 5, 33, 43). To test if these immune
responses were differentially elicited by ECTV in the presence
or absence of SPI-2, the cytokine profile in the sera of infected
mice was examined. The levels of IL-2, IL-4, IL-17A, IL-10,
IL-6, IFN-
, and TNF- were assessed at days 2, 4, 6, and 9 p.i.
Given their often rapid induction, IFN-, IL-1, and IL-18
were analyzed in addition at 0, 6, 12, and 24 h p.i. All infected
mice generated a predominantly Th1 type of cytokine re-
sponse, characterized by IFN-
, IL-18, and TNF- production.
However, IL-10 was also detected in several mice throughout
the infection (data not shown). Levels of IFN-, IL-1, IL-2,
IL-4, and IL-17A were not markedly raised at any of the time
points tested compared to uninfected mice.
Most notably, ECTV-infected mice had considerably lower
levels of serum IFN-
 than mice infected with ECTV SPI-2
mutants at 4 days p.i., while 2 days later, all infected mice
reached similar peak levels of IFN-
, decreasing by 9 days p.i.
(Fig. 6A). IL-18 release was detected in the serum only be-
tween 4 and 9 days p.i., and at 6 days p.i., the levels of the
cytokine were higher in ECTV SPI-2 mutant-infected mice
than in ECTV-infected mice (Fig. 6B). IL-18 was not detected
in the blood at any time tested before day 4 p.i. In contrast,
increased levels of TNF- in the sera of mice infected with
ECTV expressing the SPI-2 protein were found at 6 days p.i.
(Fig. 6C). No difference in IL-10 and IL-6 levels in the serum
was detected between wt virus- and mutant virus-infected mice.
Thus, in the absence of SPI-2, the host Th1 cytokine responses,
in particular IFN-
 and IL-18, are enhanced.
NK cell and CD8 T cell responses are enhanced in the
absence of SPI-2. Given the increased protection of the splenic
tissue and the Th1 cytokine response enhancement observed in
mutant-infected mice, we investigated the development and
activation of lymphocyte populations during ECTV infection
with or without SPI-2. The relative percentages of B cells, CD4
and CD8 T cells, and NK cells in the spleen and circulating in
the blood 6 days p.i. did not markedly differ between ECTV- and
ECTV SPI-2 SAD-infected mice (Fig. 7B, C, and F and data not
shown). However, because the total number of splenocytes in
ECTV SPI-2 SAD-infected mice was around double that in wt
virus-infected mice (Fig. 4D), the absolute number of each lym-
phocyte population was markedly reduced following wt virus in-
fection (Fig. 7A and E and data not shown).
FIG. 3. Liver damage induced by mousepox is reduced in the absence of SPI-2. BALB/c mice were infected s.c. with 103 PFU of ECTV or
ECTV SPI-2 SAD or mock infected. Serum was collected at 6 days p.i., and levels of the liver enzymes aspartate aminotransferase (A) and alanine
aminotransferase (B) were determined. The graphs represent means  SEM of data combined from three independent experiments. *, P  0.05
in relation to mock-infected mice. NS, not statistically significant (P 	 0.05).
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Granzyme B is an essential effector molecule for recovery
from mousepox (38, 42). Therefore, granzyme B expression in
CD8 T cells and NK cells from ECTV- and ECTV SPI-2
SAD-infected mice was assessed. At 6 days p.i., the percent-
ages of CD8- and granzyme B-positive cells in the spleen were
low (around 1%) in both ECTV- and ECTV SPI-2 SAD-
infected mice. In blood, an 2-fold-greater percentage of cells
were CD8 and expressed granzyme B in ECTV SPI-2 SAD-
infected mice than in ECTV-infected mice (Fig. 7D), although
this difference did not reach statistical significance. Ex vivo
cytotoxicity against virus-infected, major histocompatibility
complex class I (MHC-I)-matched target cells was marginal for
splenocytes from mice infected with either virus for 4 and 5
days (data not shown). In contrast, splenocytes from mice
infected with ECTV SPI-2 SAD for 6 days were able to
induce target cell lysis and were more cytotoxic than spleno-
cytes from mice infected with the wt (P  0.0077) or revertant
(P  0.0008) virus (see Fig. S3 in the supplemental material).
The proportion and total number of NK cells expressing
granzyme B in the spleen and blood were higher in mice
infected with ECTV SPI-2 SAD than in mice infected with wt
virus at 6 days p.i. (Fig. 7G, H, and I). This increased granzyme
B NK cell population accounted for approximately 25% of
the total circulating leukocytes in the blood following mutant
virus infection (Fig. 7G). The increased expression of gran-
zyme B in NK cells of ECTV SPI-2 SAD-infected mice sug-
gests an increase in the cytotoxic potential of these cells com-
pared to NK cells of wt ECTV-infected mice. At day 4 p.i., the
ex vivo cytotoxicities of splenocytes against YAC-1 cells were
similar for ECTV- and ECTV SPI-2 SAD mutant-infected
mice (Fig. 8A). However, at day 6 p.i., the ex vivo cytotoxicity
of splenocytes against YAC-1 cells was higher for ECTV
SPI-2 (P  0.0097) and ECTV SPI-2 SAD (not statistically
significant; P  0.0526) mice than for mice infected with wt or
revertant virus (Fig. 8B). Even though the increase in NK
cytotoxicity induced by the ECTV SPI-2 SAD infection was
not statistically significant with the sample size used, the two
SPI-2 mutant viruses presented similar trends, and therefore,
we believe that the increased levels of target cell lysis mediated
by ex vivo splenocytes are representative for both mutant-
infected mice compared to mice infected with ECTV express-
ing SPI-2. This result correlated with the lower granzyme B
expression in NK cells and the lower levels of IL-18 in the
blood of wt ECTV-infected mice at this time p.i. relative to
ECTV SPI-2 SAD-infected mice, suggesting that SPI-2 may
prevent optimal NK cell activation and cytotoxicity.
SPI-2 abrogates the protective NK cell response in mouse-
pox infection. To test if the vigorous NK cell response is es-
sential for resistance of BALB/c mice to infection with ECTV
SPI-2 mutants, NK cells were depleted in vivo. Both CD4
(data not shown) and CD8 lymphocyte populations (see Fig.
S4 in the supplemental material) were not markedly affected by
anti-asialo GM1 treatment, whereas the DX5 cell population
was effectively depleted (Fig. 9A). Lack of NK cells rendered
BALB/c mice as susceptible to ECTV SPI-2 SAD infection
(all animals died by day 7 p.i.) as nondepleted mice were to wt
ECTV (Fig. 9B). The liver viral loads were 10-fold and
1,000-fold increased in NK cell-depleted mice compared to
control mice when infected with wt virus or mutant virus,
respectively (Fig. 9C). Importantly, following NK cell deple-
FIG. 4. Spleen pathology caused by mousepox is reduced in the
absence of SPI-2 protein. (A to C) BALB/c mice were mock infected
(A) or infected s.c. with 103 PFU of wt ECTV (B) or ECTV SPI-2
SAD (C). The animals were sacrificed at 6 days p.i., and the spleens
were sectioned and stained with H&E. The arrows indicate the pres-
ence of pyknotic cells. (D) Total splenocyte numbers are increased in
mice infected with ECTV lacking SPI-2. Mice were infected as in
panels A to C with each virus. At day 6 p.i., the spleens were processed
for cell counting. The graph represents means  SEM of data com-
bined from two independent experiments (n  3 for each experiment).
***, P  0.0001 in relation to both wt ECTV and ECTV SPI-2 REV.
VOL. 85, 2011 EFFECT OF ECTV SPI-2 ON NK CELL RESPONSES 11175
tion, mice infected with mutant and wt viruses presented liver
viral loads that were similar in magnitude at 6 days p.i. More-
over, the depletion of NK cells in ECTV SPI-2 SAD-infected
mice resulted in pronounced tissue destruction in the spleen
and loss of splenocytes (Fig. 9D), similar to that seen in NK-
sufficient mice infected with wt virus. The NK depletion treat-
ment was not intrinsically cytotoxic because equivalent spleno-
cyte numbers were obtained from NK cell-depleted and
nondepleted, uninfected mice.
The levels of IFN-
 found in the sera of NK cell-depleted
mice infected with the mutant virus were reduced to the levels
found in NK-sufficient mice infected with the wt virus at 4 days
p.i. (Fig. 9E). In contrast, the levels of TNF- in the sera of
NK-depleted mice were remarkably high compared to nonde-
pleted mice at 6 days p.i. (Fig. 9F).
Collectively, the decreased survival, increased liver viral load,
and reduced levels of serum IFN-
 of NK cell-depleted mice
infected with ECTV SPI-2 SAD support the conclusion that NK
cells are the key effector cells for protection against mousepox in
mutant-virus-infected mice and that SPI-2 deletion counteracts
this disease-ameliorating immune pathway. Furthermore, NK
cells are the likely predominant source of early IFN-
. Thus, the
main downstream effect of SPI-2 expression is the prevention of
NK cell responses in susceptible strains.
DISCUSSION
In the present study, we establish that the ECTV SPI-2
protein is a virulence factor that prevents the induction of a
protective NK cell response in susceptible mouse strains. This
FIG. 5. ECTV lacking SPI-2 presents proportions of TUNEL cells in spleen and liver similar to those of wt ECTV. BALB/c mice were infected s.c.
with 103 PFU of wt ECTV or ECTV SPI-2 SAD. Organs collected on the indicated days p.i. were sectioned, formalin fixed, and analyzed for DNA
fragmentation with TUNEL staining. (A and B) Cells presenting green fluorescence (TUNEL) colocalized with blue fluorescence (DAPI [4,6-
diamidino-2-phenylindole]) were counted in spleen (A) and liver (B) sections. The error bars indicate SEM. (C to F) Representative pictures of spleen
(C and D) and liver (E and F) sections of mice infected with wt ECTV (C and E) or ECTV SPI-2 SAD (D and F) for 6 days and stained for TUNEL
and with DAPI.
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conclusion is based on the striking similarity seen for multiple
aspects of pathogenesis in NK cell-depleted mice infected with
the SPI-2 mutant virus compared with NK-sufficient animals
infected with wt ECTV. These similarities include viral loads in
the liver, delayed IFN-
 response, spleen pathology, and levels
of mortality (Fig. 9). In short, all the hallmarks of attenuation
due to loss of SPI-2 activity from ECTV are absent in mice
lacking NK cells.
We also found that the proportions of CD8 T cells that
express granzyme B and the ex vivo cytotoxicity of these cells
FIG. 6. IFN-
 and IL-18 cytokine levels are increased in the sera of SPI-2 mutant-infected mice. BALB/c mice were infected s.c. with 103 PFU
of ECTV, ECTV SPI-2 SAD, or ECTV SPI-2. Sera were collected at the indicated time points. IFN-
 (A), IL-18 (B), and TNF- (C) levels were
determined by cytometric bead array or ELISA. The graphs show means  SEM from combined data from three independent experiments (n 
3 for each experiment). *, P  0.05, and **, 0.001  P  0.01 in relation to ECTV.
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were elevated in mutant-infected mice (Fig. 7D; see Fig. S3 in
the supplemental material). However, it seems more likely that
the improved CD8 T cell responses observed in mice infected
with the SPI-2 mutant virus are a consequence of the enhanced
NK cell function rather than a direct effect of SPI-2 on CD8
T cells. This is because previous work has shown that lack of an
efficient NK response leads to uncontrolled virus replication
and compromises the development of CD8 T cells (14, 15).
Our data support these findings, as we also found that NK
cell-depleted ECTV-infected mice have severely lymphopenic
spleens (Fig. 9D) with reduced numbers and proportions of
CD8 T cells expressing granzyme B (see Fig. S4 in the sup-
FIG. 7. SPI-2 protein reduces the size of cytotoxic lymphocyte populations in mousepox infection. BALB/c mice infected s.c. with 103 PFU of
each virus were sacrificed at 6 days p.i. Spleens and blood were harvested for FACS staining. (A) Total numbers of CD8 splenocytes. (B and C)
Percentages of CD8 cells found in the spleen and blood, respectively. (D) Percentages of granzyme B CD8 cells. (E) Total numbers of DX5
splenocytes. (F) Percentages of DX5 cells in the spleen and blood. (G and H) Percentages of granzyme B DX5 cells. (I) Total numbers of
DX5 and granzyme B splenocytes. The graphs are the means  SEM of data pooled from three independent experiments (A, B, and D to G)
or two independent experiments (C, H, and I) (n  3 for each experiment). *, P  0.05; **, 0.001  P  0.01; and ***, P  0.0001 in relation
to both wt ECTV and ECTV SPI-2 REV. (J to M) Representative flow cytometry plots of blood lymphocyte samples from mice infected with
ECTV SPI-2 SAD (J, L, and M) or ECTV (K) shown in the bar graph in panel G. The background staining of preimmune rabbit serum was used
for gating granzyme B populations (J), and NK cell-depleted blood lymphocytes were used for gating DX5 populations (M).
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plemental material), even though the proportion of all CD8
T cells in the spleen is not affected by the absence of NK cells.
While virus attenuation was also found in other orthopoxvi-
rus SPI-2 mutants (28, 30, 31, 41, 49), this is the first time that
SPI-2 effects on NK cell function have been observed. The only
previous work to suggest an inhibitory effect on in vivo cell-
mediated immune responses by this viral protein was a report
of an increased influx of CD3 cells into the ear pinnae of
C57BL/6 mice 8 days p.i. with a CPXV crmA mutant (30). In
contrast, one study attributed the attenuation of the VACV
SPI-2 mutant virus to in vivo replication deficiency and sug-
gested that the mutant virus elicits humoral and cell-mediated
responses as efficiently as the parental virus (28). Livers and
spleens of mice infected with wt ECTV presented similar or
slightly increased numbers of apoptotic foci compared to mice
infected with mutant virus at 6 days p.i. (Fig. 5), suggesting that
an anti-apoptotic function for SPI-2 is unlikely. These obser-
vations reinforce the notion that caution must be exercised
when extrapolating findings across different infectious models
even within closely related viruses (36).
There are several pathways by which SPI-2 might inhibit a
protective NK cell response in the mousepox model. One pos-
sibility is the inhibition of killing of infected cells by blocking
either the granule exocytosis pathway, proposed to be medi-
ated mainly by granzyme B (16), or the death receptor path-
way, mediated by caspase 8. However, in vitro studies have
suggested that ECTV SPI-2 may only weakly inhibit mouse
granzyme B (50), and this serine protease restricts ECTV rep-
lication even in the presence of SPI-2 (42). We have shown
previously that the CPXV SPI-2 protein inhibits the death
receptor pathway (37), and recently, we also found that ECTV
SPI-2 blocks target cell killing by virus-immune splenocytes in
the absence of perforin (C. R. Melo-Silva, J. Pardo, M. Lobigs,
A. Koskinen, D. C. Tscharke, R. M. Buller, A. Müllbacher, and
M. Regner, unpublished data). However, perforin and the
granule exocytosis pathway are essential for mousepox recov-
ery (35, 38), and mice deficient in Fas ligand or Fas molecule
are not overtly susceptible to ECTV infection (33; Melo-Silva
et al., unpublished), suggesting that effect of SPI-2 on NK cell
responses is not only or not at all connected to inhibition of
target cell lysis.
Interestingly, we found that at 6 days p.i., ECTV-infected
mice present increased levels of TNF- in the blood compared
to ECTV SPI-2 mutant-infected mice (Fig. 6C). TNF- is a
cytokine classically associated with induction of apoptosis in
TNF receptor (TNFR)-expressing infected cells (29, 33, 46).
This cytokine binds to death receptors expressed in the plasma
membranes of target cells, and the result is activation of pro-
apoptotic caspases and cell death. However, the cytokine has
also been implicated in immunopathology (8, 17, 55). Most
ECTV-infected mice die by day 10 (Fig. 2), whereas ECTV
SPI-2 mutant-infected mice survive. Moreover, ECTV-infected
mice have higher viral loads in the liver than mutant-infected
mice at 6 days p.i. (Table 1). Taken together, these data sug-
gest that, even if the TNF- circulating in the blood induces
apoptosis in infected cells, it is not sufficient to protect ECTV-
infected mice. Therefore, we speculated that the increased
levels of TNF- in the blood of ECTV-infected mice could
contribute to disease by immunopathology. The liver and lungs
exert specialized and essential functions, and excessive non-
specific tissue damage could contribute to multiorgan failure
and death. In agreement with this notion, NK-depleted in-
fected mice presented very high levels of the cytokine 6 days
p.i., 1 day before their death (Fig. 9F).
Another putative mechanism of action is inhibition of
caspase 1, a property that was the first function assigned to an
orthopoxvirus-encoded SPI-2 protein (45). Caspase 1 converts
IL-18 and IL-1 from their inactive precursors to the biologi-
cally active cytokines (10). IL-18 is an inducer of IFN-
 and a
stimulator of NK cell activation and cytotoxicity (16, 19, 20, 40,
52). The SPI-2 inhibition of caspase 1 in, for instance, infected
macrophages or dendritic cells (DC) might deprive developing
NK cells of an environment containing IL-18, which could lead
to reduced production of IFN-
, a cytokine that is important
for recovery from mousepox (23), or to reduced NK cell cyto-
toxicity (16). The increased levels of IL-18 in the blood of mice
infected with the ECTV SPI-2 mutants (Fig. 6B) correlated
with increased NK and CD8 T cell numbers, increased gran-
zyme B expression by these cells (Fig. 7), and higher NK
cytotoxicity (Fig. 8B), suggesting that the SPI-2 inhibition of
caspase 1 activity may indeed partially affect the NK cell re-
sponse.
Similar in vivo responses were found in the present work and
in studies using the ECTV p13 mutant. The p13 protein en-
coded by ECTV is an IL-18 binding protein (BP) capable of
competing with the cytokine cellular receptor reducing IL-18-
mediated NF-B signaling (4). The ECTV p13 mutant does
not seem to affect intrinsic virus replication, and the major
consequence of reduced IL-18 signaling is a defect in NK cell
responses. Taken together, these studies highlight the impor-
tance of IL-18 in the development of an efficient NK cell
antiviral response.
FIG. 8. Increased NK cell cytotoxicity in the absence of SPI-2. Mice
were infected s.c. with 103 PFU of each virus, spleens were harvested
at 4 (A) and 6 (B) days p.i., and a standard 51Cr release assay against
YAC cell targets was performed for 6 h. Splenocytes from uninfected
mice were used as controls.
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FIG. 9. NK cells mediate survival of ECTV SPI-2 SAD-infected mice. BALB/c mice were treated with anti-asialo GM1 antibody or
preimmune serum injected i.p. at days 1, 2, and 5 in relation to infection with 103 PFU of ECTV or ECTV SPI-2 SAD. (A) Percentage of DX5
cells in the spleen and blood at 6 days p.i. The graph shows means  SEM of one representative of two independent experiments. (B) Illness signs
and survival were scored daily for 20 days. (C and D) At day 6 p.i., mice were sacrificed, liver samples were collected for plaque assay (C), and
total splenocyte numbers were determined (D). The mice were bled for serum collection at days 4 and 6 p.i., and IFN-
 (E) and TNF- (F) levels
in the serum were determined by cytometric bead assay. Panels C, D, E, and F show combined data from two independent experiments (n  3
for each experiment). The graphs show means  SEM. *, P  0.05; **, 0.001  P  0.01; ***, P  0.001 in relation to the nondepleted group.
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Given that caspase 1 also activates pro-IL-1, its inhibition
may also lead to a reduction of the pyrogenic inflammatory
response mediated by the cytokine. We could not detect sys-
temic IL-1 at any time tested. In addition, we failed to detect
any IL-1 secretion by mouse macrophages infected in vitro
with ECTV SPI-2 mutants. For instance, IL-1 secretion in-
duced by lipopolysaccharide (LPS) and ATP treatment of peri-
toneal exudate cells (32) was efficiently inhibited by ECTV
infection, regardless of SPI-2 (see Fig. S5 in the supplemental
material). We therefore believe that this is unlikely to be a
dominant pathway for initiating a cascade ultimately leading to
a protective NK cell response.
The finding that NK cells are important in recovery from
mousepox in a susceptible strain reflects previous observations
of their importance in resistant C57BL/6 mice (14, 15, 43). NK
cells are essential to curb virus spread and allow the develop-
ment of antiviral CD8 T cell and B cell responses in resistant
mice, and NK cell deficiency has been associated with suscep-
tibility in DBA/2J mice (9, 21). The important difference be-
tween resistant and susceptible strains in an s.c. infection with
ECTV is that, while C57BL/6 mice mount a strong NK cell
response even in the presence of SPI-2, in the susceptible
BALB/c strain, SPI-2 prevents NK cell development and/or
induction. The resistant phenotype may be characterized by
redundancy or stronger responses that are either inhibited or
present at lower levels in susceptible mice, as has indeed been
suggested for the inherent ability to produce IFN-
 (5, 22).
The notion of redundancy is supported by the fact that BALB/c
mice do not express mRNA for IL-12p40 (22), another activa-
tor of NK cells, suggesting that the NK cell response in
BALB/c mice may be more dependent on IL-18 than are NK
cells from C57BL/6 mice, and this is probably one of the
reasons why the virulence mediated by SPI-2 is exacerbated in
the BALB/c strain.
In conclusion, the data presented here demonstrate that the
ECTV SPI-2 protein is a virulence factor in the infection of
susceptible mice and that it plays a previously unexpected role
in the prevention of NK cell responses. This adds to the rep-
ertoire of known biological functions of SPI-2 homologues and
suggests that the genes may have been retained by different
orthopoxviruses to counter different aspects of the host re-
sponse to infection.
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